The Supreme Court yesterday issued a unanimous opinion striking down the federal government’s reduction in Medicare Part B reimbursement for 340B drugs for calendar years 2018 and 2019. As background, the Centers for Medicare & Medicaid Services (CMS), in the 2018 hospital outpatient prospective payment system (OPPS) final rule, reduced Medicare Part B payments to 340B hospitals (other than rural sole community hospitals, OPPS-exempt cancer hospitals, children’s hospitals and critical access...
By: Manatt, Phelps & Phillips, LLP
By: Manatt, Phelps & Phillips, LLP